spacer
home > pmps > autumn 2018 > brighter futures
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Brighter Futures

In its recent report, ‘Pressure on the production line: Working capital in global manufacturing’, PwC dissects the ways in which manufacturing companies are managing and using working capital. It points to the need for businesses to invest continuously in their plant and operations to remain competitive and to secure long-term stability. The report reveals that the sector’s rate of investment has seen a steady decline over the last five years, which now sits at its lowest point during that period, concluding that better management of working capital is key to generating the necessary cash for investment.

Looking specifically at the pharmaceutical sector, the everincreasing cost of bringing drugs to market means that larger pharma and biotechnology companies are constantly searching for manufacturing strategies to drive more effective development and manufacturing operations. Ongoing demand for increased production efficiency exists in the form of more automation, monitoring, and tighter process control.

Historically, lighting has not been a major consideration for the sector. For many, existing lighting solutions are considered adequate for purpose, and reinvesting in lighting is regarded as low on the list of priorities. However, a new mindset is emerging. The sector’s leaders are embracing the latest idea of light as a service (LaaS), whereby the future performance of the lighting solution is ensured by the supplier and where no capital outlay is required. These same leaders are tuned in to the energy-saving potential provided by today’s lighting solutions and the importance of the correct lighting quality to support employee performance and wellbeing.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Graeme Shaw is the Technical Application and Academy Manager at Zumtobel Group for UK and Ireland, responsible for the technical and application education of 230 people. He has a demonstrated history of working in the electrical and lighting manufacturing industry and started at Zumtobel Group 18 years ago. Prior to joining the company, Graeme worked in lighting sales and spent 10 years as a Lighting Engineer at the Grand Opera House in Belfast, Ireland.
spacer
Graeme Shaw
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

BioIVT Acquires Biological Specialty Corporation, Adds Donor Centers and Increases Its Immune Cell Capacity

BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired Biological Specialty Corporation (BSC), a supplier of human blood products and components to the life sciences research community for more than 37 years. BSC is headquartered in Colmar, PA, with two additional FDA-registered donor centers in Allentown, PA and Reading, PA.
More info >>

White Papers

Technology Solutions - Driving efficiencies, quality and operational excellence

Worldwide Clinical Trials Ltd

Clinical trials involve the entry, analysis and reporting of millions of pieces of data; year-on-year, the amount of data required to manage efficacy and safety increases exponentially. Recently, solutions available to support this activity have grown in numbers and complexity. The rise of Tablets and Smart Phones combined with the growth of Cloud or SAS solutions has resulted in the technology landscape required to support complex, global studies becoming more confusing.
More info >>

 
Industry Events

Biotech Showcase™ 2019

7-9 January 2019, Hilton San Francisco Union Square

Biotech Showcase™ is an investor and networking conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement